JDRF T1D Fund has made an undisclosed investment in TetraGenetics. Based in Arlington, Massachusetts, TetraGenetics is a biopharmaceutical company developing new treatments for autoimmune diseases. Read more >>
A startup event is taking place in Halifax next Monday that isn’t really about startups. It’s a showcase for…
read moreRegroup Mass Notification, the award-winning leader in emergency and day-to-day mass communication technology, today announced that it is joining…
read moreEleven startups in all have benefited from the “Technology in Space” prizes awarded since 2014 at MassChallenge Boston, with…
read moreCarbonite is preparing to launch a disaster recovery as a service (DRaaS) platform in the first half of 2018,…
read moreUS fish feed developer KnipBio has extended its pipeline by taking its KBM324 product candidate through the pre-commercialization stage….
read moreThe eye wear technology company, eSight, has launched the third generation of its hands-free glasses that provide instant sight…
read moreBrian Casey who lives off Poulton Road, thought he would never see again after losing his sight nearly 27…
read moreXCOR Aerospace, a pioneer in the rapid development of long-life, reusable rocket engines, has recently chosen Syncroness, Inc. of…
read more“eSight 3 is a game-changer for the legally blind. My entire career has been spent engineering sight-enabling technologies, so…
read moreMyoPro, developed by Cambridge, Massachusetts-based Myomo Inc., allows patients with partially paralyzed or weakened arms and hands to return…
read more